Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dearnaley

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 31, 2025
Moderate hypofractionated radiotherapy for localised prostate cancer: A new standard of careDavid Dearnaley
Biomed Research International|October 28, 2015
Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate CancerAnna Wilkins, David Dearnaley, Navita Somaiah
European Urology|June 24, 2009
Surveillance in stage I seminoma patients: a long-term assessmentSebastian Cummins, Thomas Yau, Robert Huddart, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Whole-body dosimetry for targeted radionuclide therapy using spectral analysisAntigoni Divoli, Antonello Spinelli, Sarah Chittenden, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2023
A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 TrialHarry Parr, Nuria Porta, Alison C Tree, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancerDavid Binnie, Antigoni Divoli, V Ralph McCready, et al.
BJU International|June 7, 2007
Does active surveillance for men with localized prostate cancer carry psychological morbidity?Katriina L Burnet, Chris Parker, David Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2012
Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable conditionVictoria Harris, Barbara Benton, Aslam Sohaib, et al.
AJR. American Journal of Roentgenology|February 24, 2012
Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapyVeronica A Morgan, Sophie F Riches, Sharon Giles, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy FractionationAnna Wilkins, Olivia Naismith, Douglas Brand, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 31, 2025
Moderate hypofractionated radiotherapy for localised prostate cancer: A new standard of careDavid Dearnaley
Biomed Research International|October 28, 2015
Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate CancerAnna Wilkins, David Dearnaley, Navita Somaiah
European Urology|June 24, 2009
Surveillance in stage I seminoma patients: a long-term assessmentSebastian Cummins, Thomas Yau, Robert Huddart, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Whole-body dosimetry for targeted radionuclide therapy using spectral analysisAntigoni Divoli, Antonello Spinelli, Sarah Chittenden, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2023
A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 TrialHarry Parr, Nuria Porta, Alison C Tree, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancerDavid Binnie, Antigoni Divoli, V Ralph McCready, et al.
BJU International|June 7, 2007
Does active surveillance for men with localized prostate cancer carry psychological morbidity?Katriina L Burnet, Chris Parker, David Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2012
Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable conditionVictoria Harris, Barbara Benton, Aslam Sohaib, et al.
AJR. American Journal of Roentgenology|February 24, 2012
Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapyVeronica A Morgan, Sophie F Riches, Sharon Giles, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy FractionationAnna Wilkins, Olivia Naismith, Douglas Brand, et al.
Pageof 9